These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26473934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Candida vaginitis: virulence, host response and vaccine prospects.
    De Bernardis F, Graziani S, Tirelli F, Antonopoulou S.
    Med Mycol; 2018 Apr 01; 56(suppl_1):26-31. PubMed ID: 29538739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.
    De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, Zurbriggen R, Moser C, Cassone A.
    Vaccine; 2012 Jun 22; 30(30):4490-8. PubMed ID: 22561143
    [Abstract] [Full Text] [Related]

  • 5. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.
    De Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A.
    Infect Immun; 1997 Aug 22; 65(8):3399-405. PubMed ID: 9234804
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective antigens and mechanisms of anti-Candida immunity.
    Antonio C.
    Nihon Ishinkin Gakkai Zasshi; 2000 Aug 22; 41(4):219. PubMed ID: 11064318
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunity to Candida.
    Fidel PL.
    Oral Dis; 2002 Aug 22; 8 Suppl 2():69-75. PubMed ID: 12164664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancing Immunity and Modulating Vaginal Microflora Against Candidal Vaginitis Through Nanoemulsion Supplemented with Porphyra Oligosaccharide as an Intravaginal Vaccine Adjuvant.
    Tsai WC, Liu FL, Huang MH, Huang CH.
    Int J Nanomedicine; 2023 Aug 22; 18():6333-6346. PubMed ID: 37954454
    [Abstract] [Full Text] [Related]

  • 16. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL.
    Int Rev Immunol; 2002 Aug 22; 21(6):515-48. PubMed ID: 12650240
    [Abstract] [Full Text] [Related]

  • 17. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X, Li T, Chen X, Wang S, Liu Z.
    BMC Microbiol; 2018 Oct 25; 18(1):166. PubMed ID: 30359236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.